Form 4 filed by FRATES JAMES M
FRATES JAMES M filed this Form 4 on AMLX (Amylyx Pharmaceuticals, Inc.) with 8 transaction rows and 4 holding rows, accepted by EDGAR 2026-11-12 21:00:08 UTC.
- Accession
- 0001193125-26-458247
- Filer
- CIK 1235598
- Filed
- 2026-11-12
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: AMLX · Amylyx Pharmaceuticals, Inc. (CIK 1658551)
- FRATES JAMES M officer (Chief Financial Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-09 | M exercised | +20,000 | $6.88 | 253,625 | D |
| Common Stock | 2026-11-09 | S sold | -7,700 | $29.3887 | 245,925 | D |
| Common Stock | 2026-11-09 | S sold | -12,300 | $30.1105 | 233,625 | D |
| Common Stock | 2026-11-10 | M exercised | +20,000 | $6.88 | 253,625 | D |
| Common Stock | 2026-11-10 | S sold | -12,800 | $30.3209 | 240,825 | D |
| Common Stock | 2026-11-10 | S sold | -7,200 | $30.9698 | 233,625 | D |
| Common Stock holding | 100,000 | I By Trust | ||||
| Common Stock holding | 15,459 | I By Trust | ||||
| Common Stock holding | 11,072 | I By Trust | ||||
| Common Stock holding | 40,000 | I By Trust | ||||
| Stock Option (right to buy) derivative | 2026-11-09 | M exercised | -20,000 | $0 | 343,835 | D |
| Stock Option (right to buy) derivative | 2026-11-10 | M exercised | -20,000 | $0 | 323,835 | D |